{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:16:11Z","timestamp":1791335771204,"version":"4.3.1"},"reference-count":55,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T00:00:00Z","timestamp":1292803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Antimony toxicity occurs either due to occupational exposure or during therapy. Occupational exposure may cause respiratory irritation, pneumoconiosis, antimony spots on the skin and gastrointestinal symptoms. In addition antimony trioxide is possibly carcinogenic to humans. Improvements in working conditions have remarkably decreased the incidence of antimony toxicity in the workplace. As a therapeutic, antimony has been mostly used for the treatment of leishmaniasis and schistosomiasis. The major toxic side-effects of antimonials as a result of therapy are cardiotoxicity (~9% of patients) and pancreatitis, which is seen commonly in HIV and visceral leishmaniasis co-infections. Quality control of each batch of drugs produced and regular monitoring for toxicity is required when antimonials are used therapeutically.<\/jats:p>","DOI":"10.3390\/ijerph7124267","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T12:05:18Z","timestamp":1292846718000},"page":"4267-4277","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":611,"title":["Antimony Toxicity"],"prefix":"10.3390","volume":"7","author":[{"given":"Shyam","family":"Sundar","sequence":"first","affiliation":[{"name":"Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Chakravarty","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2010,12,20]]},"reference":[{"key":"ref_1","unstructured":"Available online: http:\/\/www.atsdr.cdc.gov\/tfacts23.html."},{"key":"ref_2","unstructured":"Available online: http:\/\/www.health.gov.sk.ca\/water-guidelines-water-quality."},{"key":"ref_3","unstructured":"Available online: http:\/\/www.inchem.org\/documents\/iarc\/vol47\/47-11.html."},{"key":"ref_4","unstructured":"McCallum, RI (1999). Antimony in Medical History, The Pentland Press."},{"key":"ref_5","unstructured":"Available online: http:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp23.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0048-9697(87)90371-8","article-title":"Preparation of a mixed human diet material for the determination of nutrient elements, selected toxic elements and organic nutrients: A preliminary report","volume":"61","author":"Iyengar","year":"1987","journal-title":"Sci. Total Environ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-144-37632","article-title":"Retention patterns of antimony in mice following inhalation of particles formed at different temperatures","volume":"144","author":"Thomas","year":"1973","journal-title":"Proc. Exp. Biol. Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00004032-197406000-00006","article-title":"Retention of inhaled antimony-124 in the beagle dog as a function of temperature of aerosol formation","volume":"26","author":"Felicetti","year":"1974","journal-title":"Health Phys"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2214\/ajr.103.3.495","article-title":"Pneumoconiosis among workers in an antimony industry","volume":"103","author":"Cooper","year":"1968","journal-title":"Am. J. Roentgen. Rad. Ther. Nuclear Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00377752","article-title":"Antimoniosis: A particular form of pneumoconiosis. I. Etiology, clinical and x-ray findings","volume":"51","author":"Potkonjak","year":"1983","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"ref_11","unstructured":"Karajovic, D Pneumokoniosen bei arbeitern einer antimonhutte. (Cited in Public Health Goal for Antimony in Drinking Water; Prepared by Pesticide and Environmental Toxicology Section Office of Environmental Health Hazard Assessment California Environmental Protection Agency December 1997)."},{"key":"ref_12","first-page":"479","article-title":"Toxicologic study of calcium halophosphate phosphors and antimony trioxide. II. Pulmonary studies","volume":"11","author":"Gross","year":"1955","journal-title":"AMA Arch. Ind. Health"},{"key":"ref_13","first-page":"521","article-title":"Industrial antimony poisoning","volume":"23","author":"Brieger","year":"1954","journal-title":"Ind. Med. Surg"},{"key":"ref_14","first-page":"318","article-title":"Acute intoxication from antimony trichloride","volume":"23","author":"Taylor","year":"1966","journal-title":"Br. J. Ind. Med"},{"key":"ref_15","first-page":"99","article-title":"Antimony poisoning in industry","volume":"7","author":"Renes","year":"1953","journal-title":"Arch. Ind. Hyg"},{"key":"ref_16","first-page":"40","article-title":"Antimony spots","volume":"51","author":"Stevenson","year":"1965","journal-title":"Trans. St. Johns Hosp. Dermatol. Soc"},{"key":"ref_17","first-page":"392","article-title":"Dermatitis in workers exposed to antimony in a melting process","volume":"35","author":"White","year":"1993","journal-title":"J. Occup. Med"},{"key":"ref_18","first-page":"32","article-title":"The effect of antimony on reproduction","volume":"11","author":"Belyaeva","year":"1967","journal-title":"Gig. Truda. Prof. Zabol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0027-5107(72)90166-2","article-title":"Chromosome damage in human cell cultures induced by metal salts","volume":"16","author":"Paton","year":"1972","journal-title":"Mutat. Res"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/em.10102","article-title":"Genotoxic risk and oxidative DNA damage in workers exposed to antimony trioxide","volume":"40","author":"Cavallo","year":"2002","journal-title":"Environ. Mol. Mutagen"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1539\/joh.L9080","article-title":"Genotoxicity studies of heavy metals: Lead, Bismuth, Indium, Silver and Antimony","volume":"51","author":"Asakura","year":"2009","journal-title":"J. Occup. Health"},{"key":"ref_22","first-page":"532","article-title":"A curious case of antimony poisoning","volume":"531","author":"Dunn","year":"1928","journal-title":"Analyst"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0140-6736(90)90463-F","article-title":"Cot mattress biodeterioration and SIDS","volume":"335","author":"Richardson","year":"1990","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/adc.82.3.244","article-title":"Concentrations of antimony in infants dying from SIDS and infants dying from other causes","volume":"82","author":"Cullen","year":"2000","journal-title":"Arch. Dis. Child"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/JOM.0b013e3181c7514a","article-title":"A health hazard evaluation of antimony exposure in fire fighters","volume":"52","author":"Durgam","year":"2010","journal-title":"J. Occup. Environ. Med"},{"key":"ref_26","unstructured":"Niosh Safety and Health Topic: Fire Fighter Fatality Investigation and Prevention Program. Available online: http:\/\/www.cdc.gov\/niosh\/fire\/spotlight.html."},{"key":"ref_27","unstructured":"(1995). EPA 811-F-95-002j-T, Office of Water, US Environmental Protection Agency."},{"key":"ref_28","unstructured":"Available online: http:\/\/www.who.int\/water_sanitation_health\/dwq\/chemicals\/antimony.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sneader, W (2005). Drug Discovery: A History, John Wiley & Sons.","DOI":"10.1002\/0470015535"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.3.5620.713","article-title":"Urinary schistosomiasis treated with sodium antimony tartrate a quantitative evaluation","volume":"3","author":"Farid","year":"1968","journal-title":"Brit. Med. J"},{"key":"ref_31","first-page":"197","article-title":"Comparative trials of antimonial drugs on urinary schistosomiasis","volume":"38","author":"Davis","year":"1968","journal-title":"Bull. World Health Organ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jac\/31.3.327","article-title":"Leishmaniasis: some recent developments in chemotherapy","volume":"31","author":"Cook","year":"1993","journal-title":"J. Antimicrob. Chemother"},{"key":"ref_33","unstructured":"(1941). Conquest of kala-azar. Science and Culture, VI, 528\u2013534."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J. Infect. Dis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/516526","article-title":"Response to interferon-g plus antimony in Indian visceral leishmaniasis","volume":"176","author":"Sundar","year":"1997","journal-title":"J. Infect. Dis"},{"key":"ref_38","first-page":"514","article-title":"Kala-azar mortality in hospitalized cases in North Bihar, India","volume":"37","author":"Singh","year":"1989","journal-title":"J. Assoc. Physicians India"},{"key":"ref_39","unstructured":"Braunwald, E (1984). Heart Diseases, W. B. Saunders Co. [2nd ed]."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4269\/ajtmh.1998.59.139","article-title":"A cluster of cases of severe cardiotoxicity among Kala-Azar patients treated with a high-osmolarity lot of sodium antimony gluconate","volume":"59","author":"Sundar","year":"1998","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0035-9203(03)80043-3","article-title":"Sodium stibogluconate cardiotoxicity and safety of generics","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1124\/mol.105.019281","article-title":"Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents","volume":"69","author":"Kuryshev","year":"2006","journal-title":"Mol. Pharmacol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug Resistance in Leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev"},{"key":"ref_44","first-page":"3893","article-title":"Mechanism of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.1999.61.766","article-title":"High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type 1-infected patients","volume":"61","author":"Delgado","year":"1999","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.1995.52.435","article-title":"Antimony oxidation states in antileishmanial drugs","volume":"52","author":"Franco","year":"1995","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_47","first-page":"332","article-title":"Hyperamylasemia in patients with the acquired immunodeficiency syndrome","volume":"87","author":"Murthy","year":"1992","journal-title":"Am. J. Gastroenterol"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0889-8553(05)70298-3","article-title":"The pancreas in AIDS","volume":"26","author":"Cappell","year":"1997","journal-title":"Gastroenterol. Clin. North Am"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0074-02762003000100019","article-title":"High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls","volume":"98","author":"Romero","year":"2003","journal-title":"Mem. Inst. Oswaldo. Cruz"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-3156.2008.02195.x","article-title":"Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India","volume":"14","author":"Olliaro","year":"2009","journal-title":"Trop. Med. Int. Health"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/infdis\/168.3.715","article-title":"Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone","volume":"168","author":"Seaman","year":"1993","journal-title":"J. Infect. Dis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0035-9203(90)90263-E","article-title":"Treatment of visceral leishmaniasisin Kenya by aminosidine alone or combined with sodium stibogluconate","volume":"84","author":"Chunge","year":"1990","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0035-9203(92)90150-B","article-title":"Treatment of visceral leishmaniasis (kala-azar) with aminosidine (=paromomycin)-antimonial combinations, a pilot study in Bihar, India","volume":"86","author":"Thakur","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2007.77.89","article-title":"Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy","volume":"77","author":"Melaku","year":"2007","journal-title":"Am. J. Trop. Med. Hyg"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/7\/12\/4267\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:04:09Z","timestamp":1760220249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/7\/12\/4267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,20]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12]]}},"alternative-id":["ijerph7124267"],"URL":"https:\/\/doi.org\/10.3390\/ijerph7124267","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,20]]}}}